Android app on Google Play

BioMed Realty Trust, Inc. (BMR) Misses Q4 FFO by 1c; Guides FY13 FFO

February 5, 2013 4:48 PM EST Send to a Friend
BioMed Realty Trust, Inc. (NYSE: BMR) reported Q4 FFO of $0.33, $0.01 worse than the analyst estimate of $0.34. Revenue for the quarter came in at $138.77 million versus the consensus estimate of $134.72 million.

Sees FY2013 FFO of $1.36-1.44, versus the consensus of $1.38.

For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment